A medical syringe and a vial in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020.
Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% LONDON - The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K.